Real-world 24-month pain outcomes of disk percutaneous ablation and extraction versus Disc-FX nucleoplasty for lumbar discogenic pain and contained lumbar disk herniation: a single-center retrospective cohort study - Report - MDSpire
Advertisement
Real-world 24-month pain outcomes of disk percutaneous ablation and extraction versus Disc-FX nucleoplasty for lumbar discogenic pain and contained lumbar disk herniation: a single-center retrospective cohort study
Long-term Pain Outcomes at 24 Months for Disk Percutaneous Ablation and Extraction
Overview
This study compares the long-term outcomes of disk percutaneous ablation and extraction (DPAE) and Disc-FX nucleoplasty in patients with lumbar discogenic pain. At 24 months, DPAE showed a mean VAS reduction of 5.29 compared to 4.17 for Disc-FX (p < 0.001).
Background
Discogenic pain and contained lumbar disk herniation are significant contributors to chronic low back pain, necessitating effective treatment strategies. Minimally invasive techniques like DPAE and Disc-FX have emerged, yet their long-term efficacy remains under-evaluated. Understanding the comparative effectiveness of these interventions is crucial for optimizing patient outcomes.
Data Highlights
Outcome
DPAE
Disc-FX
P-value
Mean VAS Reduction
5.29 ± 2.06
4.17 ± 2.24
< 0.001
ODI Improvement
Higher
Lower
All p < 0.05
PGIC Marked Improvement
Higher
Lower
All p < 0.05
Composite Success Rate
70.0%
51.1%
All p < 0.05
Reintervention Rate
7.3%
14.8%
p = 0.047
Complication Rate
6.4%
9.1%
No significant difference
Key Findings
DPAE resulted in a mean VAS reduction of 5.29 compared to 4.17 for Disc-FX (p < 0.001).
Improvement in ODI was significantly better in the DPAE group.
Higher rates of marked improvement in PGIC were observed in the DPAE group.
The composite success rate was 70.0% for DPAE versus 51.1% for Disc-FX (all p < 0.05).
The reintervention rate was significantly lower in the DPAE group (7.3% vs. 14.8%, p = 0.047).
No statistically significant difference in complication rates between the two groups.
Clinical Implications
The findings suggest that DPAE may provide superior long-term pain relief and functional outcomes for patients with lumbar discogenic pain compared to Disc-FX. Clinicians should consider these results when discussing treatment options with patients.
Conclusion
DPAE appears to offer a more effective long-term treatment option for lumbar discogenic pain compared to Disc-FX. Further multicenter studies are needed to validate these findings.